The Rip Van Wrinkler,
Volume XIII, Issue 3, August 2009

Page 17

Stuff, Stuff, Stuff. . .


click for PDF

Posters for the Basenji Health Endowment
Lunetta/Kamen BHE Quilt, Kiafrika Azima, Kiafrika Azima 2, Twin Towers Tight Rope, The Bakers’ Dozen
Signed, limited edition, archival prints of all 5 posters still available.

FMI on how to order club stuff

Club Gear - coming soon, online storefront to order gear embroidered with club images. Stay tuned.

Part of Twin Towers Tight Rope

Collars & Slip Leads

Richard Gallione

Beautiful collars. “Master’s Pride.”
or (888) 283-7575

H.R. Hoerr / LTD Leathergoods

Leather Lure Coursing & Obedience Leashes

760/789-5643 or

Hogan Leathers:


Training, Etc.

Clean Run

The Whole Dog Journal

Affordable Agility (equipment)

HiTop Dog Training

Nancy Banask

High Goal Farm

Wendy Cerelli

Dog coats

Montana Dogware - Fido Fleece coats

Glitter lure coursing jackets + non-glitter too

Donna Rotman Miner


Omaha Vaccine or (800) 367-4444

KV Vet or (800) 423-8211

Misc. very nice stuff

Lotte Schaeffer 
Sculptures & dolls, “Serious Art with a Touch of Whimsy.”

Melissa Langston Sanford
“Wilderness Expressions,” Silver & gold charms, etc.

Hand Made Xpen Covers
by Alesia Johnson

Dog Jewelry
Jacquie Cookingham - (845) 758-8511

William & Shirley Wagner
WiSh Crafts” Basenji sun catchers, stained glass. Special orders from your own photos.  (508) 543-6651

Metropolitan Museum Store

Dog food online: 



Highly recommended books/DVDs:

Temple Grandin - "Animals in Translation"

Patricia McConnell - "The Other End of the Leash"

Turid Rugaas – “On Speaking Terms with Dogs: Calming Signals”

Leslie Nelson – “Really Reliable Recall” (DVD)

Michael Reed Gach – “Acupressure’s Potent Points”

Leslie McDevitt – “Control Unleashed”


Health Listings:

Thyroid - W. Jean Dodds DVM – Hemopet

Phone 714-891-2022, fax 714-891-2123

11330 Markon Drive, Garden Grove, CA  92841.

Forms for Thyroid testing

Dr. Dodds' Vaccine Protocol

Liver Cleansing Diet

Canine Phenome Project

CERF- Canine Eye Registration Foundation

OFA Orthopedic Foundation for Animals

Fanconi Information
Dr. Steve Gonto

NEW YORK, June 3 (Reuters) - Pfizer Inc's (PFE.N) efforts to develop new cancer drugs have yielded a breakthrough -- for dogs.

The U.S. Food and Drug Administration has approved the first cancer treatment specifically designed to treat dogs, Pfizer and the agency announced on Wednesday. The drug Palladia was approved to treat canine mast cell tumors, a potentially serious type of cancer that accounts for about 20 percent of canine skin tumors, and one that can spread to other parts of the body, including lymph nodes, if not treated.


All cancer drugs now used in veterinary medicine originally were developed for use in humans and are not specifically approved for use in animals, the FDA said. "This cancer drug approval for dogs is an important step forward for veterinary medicine," Bernadette Dunham, director of FDA's Center for Veterinary Medicine, said in a statement. "Prior to this approval, veterinarians had to rely on human oncology drugs without knowledge of how safe or effective they would be for dogs," she said. Pfizer said it would begin selling Palladia in early 2010, but will make the oral drug available to certain veterinary oncology specialists prior to that.


Palladia works by killing tumor cells and by cutting off the blood supply to the tumor. The pill must be taken every other day and the dog will likely have to be on the therapy for several months or longer, depending on tumor response, Pfizer said.


Pfizer declined to divulge the cost of the treatment or to forecast what annual Palladia sales might be. The world's biggest drugmaker said it will likely announce the price of the drug sometime this summer. Treatment with new cancer drugs for humans tends to cost tens of thousands of dollars per patient, and the majority of pet owners do not have health insurance for their dogs. In clinical trials, some 60 percent of dogs treated with Palladia, known chemically as toceranib, had their tumors disappear, shrink or stop growing, Pfizer said. Pfizer Animal Health estimates 1.2 million new canine cancer cases are reported in the United States every year.